Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing aspirin and butalbital and caffeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and butalbital and caffeine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aspirin- and caffeine- and dihydrocodeine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aspirin- and butalbital- and caffeine- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin- and pravastatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin- and carisoprodol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin- and meprobamate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and methocarbamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 300 mg and codeine 8 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 81 mg and pravastatin 40 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg and carisoprodol 200 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg and codeine 30 mg oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aspirin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has precise active ingredient |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aspirin and isosorbide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin- and codeine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin- and caffeine- and dextropropoxyphene-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing aspirin and metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin and carisoprodol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and butalbital and caffeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine and dextropropoxyphene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aspirin and pentazocine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine and orphenadrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and carisoprodol and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine and cinnamedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and codeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and cyclizine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and glycine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and isosorbide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and meprobamate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and methocarbamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and oxycodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and papaveretum (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and butalbital and caffeine and codeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and metoclopramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and omeprazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and paracetamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and pravastatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and caffeine and dihydrocodeine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin and butalbital and caffeine and codeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and butalbital and caffeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and caffeine and dextropropoxyphene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin and caffeine and dihydrocodeine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin and caffeine and orphenadrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aspirin and caffeine and paracetamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and carisoprodol and codeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and carisoprodol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and codeine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and dipyridamole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and meprobamate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aspirin and methocarbamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin and omeprazole only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and oxycodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin only product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aspirin and metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aspirin and pravastatin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to aspirin |
Causative agent (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 81 mg chewable tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 81 mg chewable tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 500 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 500 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 600mg pessary |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 600mg pessary |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 165 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 325 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 75 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 81 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 81 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 120 mg rectal suppository |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aspirin 120 mg rectal suppository |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 200 milligram/1 each conventional release rectal suppository (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 975 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aspirin 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aspirin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |